Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral intravitreal bevacizumab versus retinal photocoagulation for retinopathy of prematurity
jRCT1091220083Recruiting
- Sponsor
- Nobuhisa Naoi, MD Department of Ophthalmology, School of medicine University of Miyazaki
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of bevacizumab in retinopathy of prematurity (ROP) (2 arms), sponsored by Nobuhisa Naoi, MD Department of Ophthalmology, School of medicine University of Miyazaki. Primary endpoint: retinal status. Started Mar 2012; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on jRCT1091220083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220083.